Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia
Clinical trial NCT03575325 · COMPLETED
Trial details
- NCT number
- NCT03575325
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2021-06-07
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.